EXOZ CIK: 2010788

eXoZymes Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
1.21
FY24:
10.8
FY25:
3.94
(positive)
Change from FY23 to FY25
millions USD
FY23:
2.34
FY24:
2.21
FY25:
2.03
Total assets
Change from FY23 to FY25
millions USD
FY23:
3.56
FY24:
13.0
FY25:
5.97

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
2.42
FY24:
1.33
FY25:
1.57
(negative)
Change from FY23 to FY25
millions USD
FY23:
1.53
FY24:
1.28
FY25:
1.01
(positive)
Change from FY23 to FY25
millions USD
FY23:
−0.38
FY24:
10.4
FY25:
3.40
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
3.56
FY24:
13.0
FY25:
5.97

All amounts in millions USD Data source:SEC EDGAR